CANCERFebruary 2012Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukaemia
HAEMATOLOGYFebruary 2012Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma
CANCERFebruary 2012Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: The phase II VERTICAL study
